임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
44건 표시
- 2상모집 중· Central Centrifugal Cicatricial AlopeciaDeucravacitinib in the Treatment of Cicatricial Alopecias
협력: BMS
- 2상모집 중· Phase 2 StudyA Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
협력: BMS
- 2상모집 중· Cutaneous MelanomaNeo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
협력: BMS
- 2상모집 중· Recurrent GlioblastomaA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (PDAC)A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중· Basal Cell CarcinomaNeoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
협력: BMS
- 2상모집 중· Lupus Erythematosus, SystemicA Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
리드: BMS
- 2상모집 중· Smouldering MyelomaIsatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
협력: BMS, 사노피
- 2상모집 중· Pancreatic Adenocarcinoma MetastaticMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
협력: BMS, GSK
- 2상모집 중· CCUS Clonal Cytopenia of Undetermined SignificanceLuspatercept for Clonal Cytopenias of Uncertain Significance
협력: BMS
- 2상모집 중· Renal Cell Carcinoma, Clear CellA Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
협력: BMS
- 2상모집 중· Limited Stage Small Cell Lung CancerBMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
협력: BMS
- 2상모집 중· Clonal Cytopenia of Undetermined SignificanceEnasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
협력: BMS
- 2상모집 중· Cutaneous Squamous Cell CarcinomaNeoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
협력: BMS
- 2상모집 중· Melanoma Stage IIINeoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
협력: BMS
- 2상모집 중· Refractory Multiple MyelomaIberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
협력: BMS
- 2상모집 중· Multiple MyelomaIberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
협력: BMS
- 2상모집 중· Uterine Cervical NeoplasmsNivolumab-ipilimumab and Chemoradiation for Cervical Cancer
협력: BMS
- 2상모집 중· Graft Vs Host DiseaseExtended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
협력: BMS
- 2상모집 중· Non Small Cell Lung CancerBrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
협력: BMS
- 2상모집 중· Interstitial Lung DiseaseAbatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
협력: BMS
- 2상모집 중· Smoldering Plasma Cell MyelomaIberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
협력: BMS
- 2상모집 중· Hepatocellular CarcinomaNeoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
협력: BMS
- 2상모집 중· Metastatic Breast CancerImmune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
협력: BMS
- 2상모집 중· Breast CancerPre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
협력: BMS
- 2상모집 중· Melanoma Stage IvAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
협력: BMS
- 2상모집 중· Lymphoma, Non-HodgkinCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
협력: 아스트라제네카, BMS, 화이자, 로슈
- 2상모집 중· Colon CarcinomaNeoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
협력: BMS
- 2상모집 중· Squamous Cell Carcinoma of the SkinNivolumab for Treatment of Squamous Cell Carcinoma of the Skin
협력: BMS
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
- 2상모집 중· Lymphoma, Non-HodgkinTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
협력: 아스트라제네카, BMS, 일라이 릴리, 노바티스, 화이자, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.